Centre For Clinical Research And Biostatistics (CCRB)

Back

1 Unique Trial Number (assigned by CCRB)

CUHK_CCRB00619

2 Trial Registration Date

2018-08-28

i Registration Status

Prospective

3 Secondary IDs

2018.246

4 Source(s) of Funding

NA

5 Primary Sponsor

NA

6 Secondary Sponsor

NA

Function

Not Applicable

Please specify

7 Responsible Contact Person (public contact person for patients interested in participating)

i Name

Dr. Chow Kai-Ming

ii Address

Department of Medicine and Therapeutics
Prince of Wales Hospital

iii Phone

5569-6007

iv Email

ckm818@ha.org.hk

v Affiliation

Department of Medicine and Therapeutics, Prince of Wales Hospital

vi Country

Hong Kong

8 Research Contact Person (person to contact for scientific inquiries)

i Name

Kai Ming CHOW

ii Address

Department of Medicine and Therapeutics
Prince of Wales Hospital

iii Phone

5569-6007

iv Email

ckm818@ha.org.hk

v Affiliation

Department of Medicine and Therapeutics, Prince of Wales Hospital

vi Country

Hong Kong

9 Official Scientific Title of the Study

Staff Experience Survey on the System of Patient Discharge Information Summary (PDIS)

10 Public Title

Staff Experience Survey on the System of Patient Discharge Information Summary (PDIS)

i Public Title in Chinese 研究名稱

NA

11 Short Title (Optional)

12 Countries of Recruitment

Hong Kong

13 Research Ethic Review

i Has the study received appropriate ethics approval?

Yes

ii When is the approval date?

2018-06-20

iii Full Name of IRB/IEC

Joint CUHK-NTEC Clinical Research Ethics Committee

Please specify

iv IRB/IEC approval reference number

2018.246

14 Medical Condition Being Studied

NA

15 Intervention

i Types of intervention

Other

Please specify

No procedure/ treatment will be carried through out the studies.

ii Description/ name of Intervention/article

NA

iii Dosage form of the intervention

NA

iv Dosage of the intervention

NA

v Duration of the intervention

NA

vi Frequency of the intervention

NA

16 Comparative Treatments

i Description/ name of comparative treatments

NA

ii Dosage form of the comparative treatments

NA

iii Dosage of the comparative treatments

NA

iv Duration of the comparative treatments

NA

v Frequency of the comparative treatments

NA

17 Key Inclusion and Exclusion Criteria

i Inclusion Criteria

Frontline healthcare professionals including doctors and nurses working in the department involved;

Able to read and understand English

ii Exclusion Criteria

NA

iii Age Minimum

18

iv Age Maximum

999

v Gender

Both Male and Female

18 Study Type

Observational

19 Study Design

i Randomization

Not Applicable

Please specify

ii Nature of control

Not Applicable

iii Degree of masking

Not Applicable

If Single-blind, who will be masked?

iv Group Assignment

Not Applicable

v Study Phase

Other

Please specify

Cross-sectional survey

vi Study Objectives (Optional)

20 Anticipated trial start date

2018-08-29

21 Target Sample Size

1800

22 Recruitment Status

Recruiting

23 Primary Outcome

i The Name of the outcome

The findings can provide a reference for future improvement on patient discharge information giving.

ii The metric or method of measurement used

NA

iii The timepoint(s) of primary interest

NA

24 Secondary Outcome

i The Name of the outcome

NA

ii The metric or method of measurement used

NA

iii The timepoint(s) of primary interest

NA

25 Study Information/Publication

i Study Information/Publication Available?

No

ii Link to Study Information/Publication

26 Last Update Date

2018-12-05

27 Primary Registry and Trial Identifying Number

28 Date of Registration in Primary Registry

Back

Trial History Detail on 2018-09-03